Kilitch Drugs (India) Ltd.
| BSE: 524500 |
Sector: Health care |
| NSE: KILITCH |
ISIN Code: INE729D01010 |
|
BSE
00:00 | 18 Aug
|
169.75
|
0.35
(0.21%)
|
OPEN
170.50
|
HIGH
171.25
|
LOW
167.55
|
|
NSE
00:00 | 18 Aug
|
168.65
|
-2.20
(-1.29%)
|
OPEN
174.90
|
HIGH
174.90
|
LOW
167.15
|
| OPEN |
170.50 |
| PREVIOUS CLOSE |
169.40 |
| VOLUME |
110 |
| 52-Week high |
276.40 |
| 52-Week low |
144.30 |
| P/E |
25.60 |
| Mkt Cap.(Rs cr) |
273 |
| Buy Price |
0.00 |
| Buy Qty |
0.00 |
| Sell Price |
0.00 |
| Sell Qty |
0.00 |
| OPEN |
174.90 |
| PREVIOUS CLOSE |
170.85 |
| VOLUME |
5043 |
| 52-Week high |
275.10 |
| 52-Week low |
145.00 |
| P/E |
25.60 |
| Mkt Cap.(Rs cr) |
273 |
| Buy Price |
0.00 |
| Buy Qty |
0.00 |
| Sell Price |
0.00 |
| Sell Qty |
0.00 |
| OPEN |
170.50 |
| CLOSE |
169.40 |
| VOLUME |
110 |
| 52-Week high |
276.40 |
| 52-Week low |
144.30 |
| P/E |
25.60 |
| Mkt Cap.(Rs cr) |
273 |
| Buy Price |
0.00 |
| Buy Qty |
0.00 |
| Sell Price |
0.00 |
| Sell Qty |
0.00 |
| OPEN |
174.90 |
| PREVIOUS CLOSE |
170.85 |
| VOLUME |
5043 |
| 52-Week high |
275.10 |
| 52-Week low |
145.00 |
| P/E |
25.60 |
| Mkt Cap.(Rs cr) |
272.96 |
| Buy Price |
0.00 |
| Buy Qty |
0.00 |
| Sell Price |
0.00 |
| Sell Qty |
0.00 |
Kilitch Drugs (India) Ltd. (KILITCH) - Company History
|
Incorporated in May '92 as a public limited company Kilitch Drugs (India) (KDIL) went public in Feb.'94 to set up a pharmaceutical formulation plant at Thane to manufacture pharmaceutical products in the form of tablets capsulesliquid orals ointments creams and injectables. Even before the plant was commissioned the company came out with a rights issue in Oct.'95 to expand the injectible capacity. Commercial production at the plant at Thane commenced in 1996. The company has two divisions - O T C and ethical.A Pharmaceutical formulation plant at Sana'a Republic of Yemen was set up at a cost of Rs 15 crore by entering into an agreement with Al-Fath Trading Corporation.It also entered into an agreement with a Miami company for the export of their medicine to West Indies south and central America.The company entered into a contract with one of the leading company in the Republic of Yemen which it had set up at a cost of Rs 2.5-cr tanning unit which was implemented in the year 1995-96. The company had set up a bulk drug unit at Patalganga Maharashtra for producing raw materials for formulations. The company exports to Sudan Yemen middle-east Miami and certain south American companies. KDIL started marketing a range of injectables from the factory on ethical basis. The company also introduced a new product clue-plus Bon-Bon Gripe Water and Kilitch Balm.
|
Quick Links for Kilitch Drugs (India):
